Biolytix

Biolytix AG is a Swiss contract research and testing laboratory founded in 1998 (not 2016 as some data suggests), offering accredited analytical services primarily in diagnostics, food safety, and environmental hygiene. Its business model is service-based, leveraging established platforms like PCR and ELISA to perform testing for allergens, GMOs, pathogens, and genetic analyses. The company is revenue-generating, privately held, and actively invests in R&D to develop new analytical methods and holds patents, positioning itself as a specialized partner for industry and research clients.

Accredited application of core analytical technologies including real-time PCR, ELISA, DNA/RNA extraction, genotyping, and GeneChip analysis for testing and research services.

Biolytix competes in the fragmented contract testing market against global giants like Eurofins, SGS, and Q2 Solutions, as well as many regional and specialized laboratories. Its differentiation is based on its Swiss quality branding, ISO 17025 accreditation, specific expertise in PCR/ELISA applications, and active R&D for novel methods.